Featured Speaker

Teri Loxam

Terri Loxam currently serves as CHief Operating Officer and Chief Financial Officer at Kira Pharmaceuticals. She is an accomplished professional with a diverse background in Strategy, Investor Relations, Finance and Communications. Prior to Kira, Teri was Chief Financial Officer at SQZ Biotech (NYSE: SQZ). In this role, Teri led the company’s financial operations, including financial strategy, accounting, financial planning and analysis, risk management, tax, and treasury, as well as overseeing the investor relations and communications/public relations functions. As CFO, Teri helped raise over $200M for SQZ.

Before joining SQZ Biotech, Teri served as Sr. Vice President of Investor Relations and Global Communications at Merck, a global pharmaceutical company. In this position, Teri led internal and external communications efforts globally, including corporate and financial media relations, product communications, public affairs, and employee communications as well as its investor relations and investment community interactions.  Prior to Merck, Teri was Vice President of Investor Relations for IMAX Corporation (NYSE: IMAX), where she reshaped the entertainment company's investor strategy, helping the company to convert its investor base and go public in China with an IPO on the Hong Kong Exchange.  Teri also spent over a decade at Bristol Myers Squibb in a variety of roles of increasing responsibility across Strategy, Treasury, and Investor Relations.

Teri started her career as a marine biologist and worked at Sea World of San Diego for several years before making a transition into business. 

She serves on the Board of Vaxcyte (NASADA: PCVX) and as an advisor to Cariol Therapeutics (NASDAQ: CRDL). 

Teri holds an MBA from the University of California, Irvine and a Bachelor of Science  in Biology from the University of Victoria, B.C. Canada.